Keynote Session: Reducing Racial Disparities in Oncology—Recommendations for Implementing Guideline-Adherent Cancer Care
Author:
Chambers Shonta,Harrington Elizabeth,Lacasse Lisa A.,Winn Robert,Schatz moderated by Alyssa A.
Abstract
Research shows that racial disparities exist in the delivery of guideline-adherent cancer care, and that non-White patients are less likely to receive guideline-concordant care than White patients, leading to worse health outcomes. However, these disparities are not often addressed. The Elevating Cancer Equity initiative aims to address these disparities through policy-change recommendations developed by a working group and informed by data from patients/caregivers and oncologists. The hope is that the results of these surveys and the resultant recommendations will be a step toward cancer care equity in the United States.
Funder
AbbVie, Bluebird bio, Bristol Myers Squibb, Genentech, GlaxoSmithKline, Janssen, Lilly, Merck, MorphoSys, Pfizer, Regeneron, Sanofi, and Taiho
Publisher
Harborside Press, LLC